Table 1.

Hemoglobin-based oxygen carriers /HBOCs) associated adverse events ¹.

Transient hypertension

Gastrointestinal symptoms

Pancreatic and liver enzyme elevation

Myocardial infarction; cardiac arrhythmias

Renal Injury

Mortality

¹ Some of the most commonly reported adverse events in human trials with current generation HBOCs (for further details see recent summaries of the clinical data presented by manufactures on these HBOCs) [6,28].